Kauffman Fellows

Kauffman Fellows is a global network of venture capitalists, offering a two-year executive coaching program to its members. This program facilitates access to networking events and provides tailored support. The organization is headquartered in Austin, Texas.

Claire England

Limited Partner

Collin West

Co-Founding Partner, Kauffman Fellows Fund

12 past transactions

Flash

Series B in 2021
Flash is a company based in São Paulo, Brazil, that specializes in providing flexible benefits solutions. Founded in 2019, it has transformed traditional food vouchers by integrating a MasterCard, a user-friendly application, and a human resources platform into a single device. This innovative approach allows for the consolidation of various employment benefits into one centralized location, offering a socially responsible alternative for employees. By utilizing its proprietary card, Flash enables employees to easily access and manage their entitled benefits, enhancing convenience and flexibility in the workplace.

ICON

Series A in 2020
ICON is a construction technologies company that focuses on revolutionizing homebuilding through the use of 3D printing, robotics, software, and advanced materials. The company specializes in constructing single-story, mid-size homes, particularly in developing countries, allowing for faster and more cost-effective building compared to traditional methods. By leveraging innovative technologies, ICON aims to address the housing needs of underserved communities, streamlining the construction process for engineers and builders alike.

Sidecar Health

Venture Round in 2020
Sidecar Health is an insurtech company that provides a personalized health insurance platform designed to enhance transparency and customization in healthcare coverage. The platform allows users to create tailored insurance plans that align with their specific coverage needs and financial situations. It emphasizes clarity regarding medical costs and payout structures, ensuring users understand their expenses. Additionally, Sidecar Health facilitates quick and seamless transactions, enabling consumers to pay for medical services directly at their chosen doctor's office or pharmacy using a credit card. This approach empowers individuals to access suitable and affordable health insurance options while streamlining the payment process.

Tally

Series C in 2019
Tally is a consumer technology company established in 2015, focused on financial automation with a particular emphasis on credit management. The company developed an innovative platform that addresses credit card debt, helping users save money on interest and avoid unnecessary charges. Tally's services include automated tracking of credit card balances and due dates, debt management, late fee protection, and the provision of a line of credit. By simplifying and automating these financial tasks, Tally empowers individuals to manage their finances more effectively, ultimately allowing them to reduce stress related to money and focus on their personal goals.

Carta

Series E in 2019
Carta, Inc., established in 2012 and headquartered in Palo Alto, California, operates as a SEC-registered transfer agent for private companies. Its core business is an online platform that facilitates electronic management of equity for corporations, involving shareholders, employees, auditors, and legal counsel. The platform offers services such as cap table management, corporate governance, 409A valuations, compliance, and electronic stock issuance. It serves venture-backed small businesses, enterprises, and pre-IPO companies in the United States and internationally. Additionally, Carta aims to simplify private market investments and participation through its platform, fostering growth and transparency in the private capital sector.

Groww

Series A in 2019
Groww is a Bengaluru-based investment platform founded in 2017 by Lalit Keshre, Harsh Jain, Neeraj Singh, and Ishan Bansal. It offers users direct access to invest in mutual funds, gold, and US stocks via its simplified, paperless interface. The platform leverages data science to provide insights and facilitate systematic investment planning, making it accessible for new investors. Additionally, Groww allows users to apply for personal loans and pay bills through their application.

Groww

Series A in 2019
Groww is a Bengaluru-based investment platform founded in 2017 by Lalit Keshre, Harsh Jain, Neeraj Singh, and Ishan Bansal. It offers users direct access to invest in mutual funds, gold, and US stocks via its simplified, paperless interface. The platform leverages data science to provide insights and facilitate systematic investment planning, making it accessible for new investors. Additionally, Groww allows users to apply for personal loans and pay bills through their application.

Catalog

Seed Round in 2017
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Zoom

Series D in 2017
Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and content sharing. It has an easy, reliable cloud platform for video and audio conferencing, collaboration, chat, and webinars across mobile devices, desktops, telephones, and room systems.

Ligandal

Angel Round in 2016
Ligandal Inc. is a biotechnology company based in Oakland, California, focused on developing therapeutic nanotechnologies for precision medicine. Founded in 2013 and originally named Ligandal Technology LLC, the company specializes in creating a delivery platform aimed at curing and treating diseases through advanced gene therapies. Ligandal's technology utilizes a ligand discovery engine to design materials that can transport a variety of nucleic acids and proteins, including CRISPR and mRNA, to specific cell types with high accuracy. Their innovative approach incorporates peptide-based technologies for gene therapy, gene editing, regenerative medicine, and immunotherapy. Ligandal's initial applications of its technology target areas such as hematology, immuno-oncology, and infectious diseases, facilitating precise delivery of genetic materials and improving therapeutic outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.